Australia's most trusted
source of pharma news
Posted 12 May 2022 PM
Despite the supply of BMS' Orencia "improving" the TGA has extended a Serious Scarcity Substitution Instrument (SSSI) until the end of June.
The disease-modifying anti-rheumatic drug is used to treat several types of arthritis and is listed on the PBS for severe active rheumatoid arthritis.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.